intermedia ATCC 29909 (AALF00000000), Y. frederiksenii ATCC 33641 (AALE00000000), Y. mollaretii ATCC NCT-501 price 43969 (AALD00000000), Y. bercovieri ATCC 43970 (AALC00000000), Y. rohdei ATCC 43380 (ACCD00000000) and Y. ruckeri ATCC 29473 (ACCC00000000). (DOCX 649 KB) Additional 2: Analysis of Y. enterocolitica LPS by DOC-PAGE and silver staining. The picture is compiled of gel images with different LPS types as indicated above the lanes by the LPS type codes that are explained in
the text box. Please note that LPS types A2, B1c, B1d, B2a, B2c and B4 are not shown. The gel regions where O-PS and lipid A (LA) plus core migrate are indicated by arrows. (DOCX 230 KB) References 1. Burnens AP, Frey A, Nicolet J: Association between clinical presentation, biogroups and virulence attributes of Yersinia enterocolitica strains in human diarrhoeal disease. Epidemiol Infect 1996, 116:27–34.PubMedCrossRef 2. Morris JG Jr, Prado V, Ferreccio C, Robins-Browne RM, Bordun AM, Cayazzo M, Kay BA, Levine MM: Yersinia enterocolitica isolated from two cohorts of young
children in Santiago, Chile: incidence of and lack of correlation between illness and proposed virulence factors. J Clin Microbiol 1991, 29:2784–2788.PubMed 3. Ratnam S, Mercer E, Picco B, Parsons S, Butler R: A nosocomial www.selleckchem.com/products/frax597.html outbreak of diarrheal disease due to Yersinia enterocolitica serotype 0:5, biotype 1. J Infect Dis 1982, 145:242–247.PubMedCrossRef 4. Greenwood MH, Hooper WL: Excretion of Yersinia spp. associated with consumption of pasteurized milk. Epidemiol Infect 1990, 104:345–350.PubMedCrossRef 5. Ebringer R, Colthorpe D, Burden G, Hindley C, Ebringer A: Yersinia enterocolitica biotype I. Diarrhoea
and episodes of HLA B27 related ocular and rheumatic inflammatory disease in South-East England. Scand J Rheumatol 1982, 11:171–176.PubMedCrossRef 6. Skurnik M, Nurmi T, Granfors K, Koskela M, Tiilikainen AS: Plasmid associated antibody production against Yersinia enterocolitica in man. Scand J Infect Dis 1983, 15:173–177.PubMed 7. Huovinen E, Sihvonen L, Virtanen M, Haukka K, Siitonen A, Kuusi M: Symptoms and sources of Yersinia enterocolitica -infection: a case–control study. BMC Infect Dis 2010, tuclazepam 10:122–131.PubMedCrossRef 8. Grant T, Bennett-Wood V, Robins-Browne RM: Characterization of the interaction between Yersinia enterocolitica biotype 1A and phagocytes and epithelial cells in vitro. Infect Immun 1999, 67:4367–4375.PubMed 9. McNally A, Dalton T, Ragione RML, Stapleton K, Manning G, Newell DG: Yersinia enterocolitica isolates of differing biotypes from humans and animals are adherent, invasive and persist in macrophages, but differ in cytokine secretion profiles in vitro. J Med Microbiol 2006, 55:1725–1734.PubMedCrossRef 10. Singh I, Virdi JS: Interaction of Yersinia enterocolitica biotype 1A strains of diverse origin with cultured cells in vitro. Jpn J Infect Dis 2005, 58:31–33.PubMed 11. Nair GB, Takeda Y: The heat-stable enterotoxins. Bucladesine Microb Pathog 1998, 24:123–131.